Gumansing, Eleza L.
HRN: 25-54-35 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/31/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/31/2024
08/14/2024
IV
2.25gms
Q8
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes